BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30926638)

  • 21. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis.
    Lee JH; Kang MJ; Han HY; Lee MG; Jeong SI; Ryu BK; Ha TK; Her NG; Han J; Park SJ; Lee KY; Kim HJ; Chi SG
    Clin Cancer Res; 2011 Dec; 17(24):7551-62. PubMed ID: 21980136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
    Gonçalves V; Matos P; Jordan P
    Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro.
    Li M; Wang X; Liu M; Qi X; Li J
    Biomed Pharmacother; 2014 Jun; 68(5):527-35. PubMed ID: 24986326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
    Zou W; Ma X; Hua W; Chen B; Cai G
    Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance.
    Wang F; Liu R; Lee SW; Sloss CM; Couget J; Cusack JC
    Oncogene; 2007 Mar; 26(14):2006-16. PubMed ID: 17001310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy.
    Li X; Wu Z; An X; Mei Q; Bai M; Hanski L; Li X; Ahola T; Han W
    Elife; 2017 Aug; 6():. PubMed ID: 28820388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway.
    La X; Zhang L; Li Z; Li H; Yang Y
    J Agric Food Chem; 2019 Mar; 67(9):2510-2518. PubMed ID: 30741544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer.
    Li Q; Chen Y; Zhang D; Grossman J; Li L; Khurana N; Jiang H; Grierson PM; Herndon J; DeNardo DG; Challen GA; Liu J; Ruzinova MB; Fields RC; Lim KH
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31527315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
    Cusack JC; Liu R; Houston M; Abendroth K; Elliott PJ; Adams J; Baldwin AS
    Cancer Res; 2001 May; 61(9):3535-40. PubMed ID: 11325813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
    Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
    Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
    Cusack JC; Liu R; Baldwin AS
    Cancer Res; 2000 May; 60(9):2323-30. PubMed ID: 10811101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts.
    Fenouille N; Grosso S; Yunchao S; Mary D; Pontier-Bres R; Imbert V; Czerucka D; Caroli-Bosc FX; Peyron JF; Lagadec P
    J Pathol; 2012 May; 227(1):118-29. PubMed ID: 22069124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rac1b enhances cell survival through activation of the JNK2/c-JUN/Cyclin-D1 and AKT2/MCL1 pathways.
    Li G; Ying L; Wang H; Wei SS; Chen J; Chen YH; Xu WP; Jie QQ; Zhou Q; Li YG; Wei YD; Wang YP
    Oncotarget; 2016 Apr; 7(14):17970-85. PubMed ID: 26918455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LPS Upregulated VEGFR-3 Expression Promote Migration and Invasion in Colorectal Cancer via a Mechanism of Increased NF-κB Binding to the Promoter of VEGFR-3.
    Zhu G; Huang Q; Zheng W; Huang Y; Hua J; Yang S; Zhuang J; Wang J; Chang J; Xu J; Ye J
    Cell Physiol Biochem; 2016; 39(5):1665-1678. PubMed ID: 27639612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
    He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.